Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 8 Issue 8

Determinants of COVID-19 Vaccine Hesitancy of the Population of the Gaweye Health District (DS) in Niger

Boulama Mamadou Boulama Malam1*, Moussa Saley Sahada1, Ayouba Tinni Ismael2, Gado Amadou Mahamadou1, Daouda Mamane Aboubacar1, Aissa Attinine1 and Eric Adehossi Omar3

1National Hospital of Niamey, Infectious Diseases Department, Niamey, Niger
2National Hospital of Niamey, Rheumatology Department, Niamey, Niger
3Reference General Hospital of Niamey, Internal Medicine Department, Niamey, Niger

*Corresponding Author: Boulama Mamadou Boulama Malam, National Hospital of Niamey, Infectious Diseases Department, Niamey, Niger.

Received: June 24, 2024; Published: July 29, 2024

Abstract

Introduction: One of the most promising strategies for reducing the transmission of COVID-19 is vaccination. It is in this context that we initiated this study, the objective of which was to study the determinants of hesitancy to vaccinate against COVID-19 among the population of the DS of Gaweye.

Method: This was a cross-sectional, descriptive and analytical study. The data was collected from August 15 to 31, 2022. The study population consisted of people aged 18 and over in the general population of the Gaweye health district. The data were collected using a questionnaire during an individual interview after informed consent and then analyzed with R software.

Results: A total of 436 people were surveyed. In our study, 264 people surveyed, or 60.56%, were hesitant to be vaccinated against COVID-19. Respondents in the 25-59 age group were 2.71 times more likely to be hesitant to get vaccinated. Furthermore, respondents who thought that it was not important to be vaccinated had an 8.66 times the risk of hesitating to be vaccinated. Respondents who did not trust health workers were 6.96 times more likely to hesitate to get vaccinated. Respondents who did not recommend the coronavirus vaccine to others were 59.59 times more likely to be hesitant to get vaccinated.

Conclusion: It appears from our study that the majority of respondents were hesitant to be vaccinated (60.56%) and several influencing factors were found that can be used to implement strategies so that the population better accepts vaccination.

 Keywords: Vaccine Hesitancy; COVID-19; Vaccination; Niger

References

  1. Zhu N., et al. “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. The New England Journal of Medicine 8 (2020): 727‑733.
  2. Bauduer F. “The COVID-19 pandemic: back to the future or the never-ending battle between humans and microbes”. Medical Press Form6 (2020): 655‑662.
  3. Wu Y., et al. “SARS-CoV-2 is an appropriate name for the new coronavirus”. Lancet Lond Engl.10228 (2020): 949‑950.
  4. Coronavirus disease (COVID-19) (2024).
  5. Khubchandani J., et al. “COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment”. Journal of Community Health2 (2021): 270‑277.
  6. Sherman SM., et al. “COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey”. Human Vaccines Immunotherapy 6 (2021): 1612‑1621.
  7. A B., et al. “COVID-19 vaccine hesitancy and related fears and anxiety”. International Immunopharmacology 97 (2021).
  8. Anjorin AA., et al. “Will Africans take COVID-19 vaccination?” PLOS ONE12 (2021): e0260575.
  9. Robinson E., et al. “International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples”. Vaccine15 (2021): 2024‑2034.
  10. Faye O., et al. “Urban epidemic of dengue virus serotype 3 infection, Senegal, 2009”. Emerg Infectious Disease3 (2014): 456‑459.
  11. Ba MF., et al. “Factors associated with COVID-19 vaccine hesitancy in Senegal: A mixed study”. Human Vaccines Immunotherapy5 (2020): 2060020.
  12. MacDonald NE, SAGE Working Group on Vaccine Hesitancy. “Vaccine hesitancy: Definition, scope and determinants”. Vaccine 34 (2015): 4161‑4164.
  13. Lazarus JV., et al. “A global survey of potential acceptance of a COVID-19 vaccine”. Nature Medicine 2 (2021): 225‑228.
  14. “Assessment of Vaccine Hesitancy to a COVID-19 Vaccine in Cameroonian Adults and Its Global Implication” (2024).
  15. Slb F., et al. “Factors influencing hesitancy towards adult and child COVID-19 vaccines in rural and urban West Africa: a cross-sectional study”. BMJ Open4 (2022).
  16. Ba MF., et al. “Acceptability of contact management and care of simple cases of COVID-19 at home: a mixed-method study in Senega”. (2021).
  17. Momplaisir F., et al. “Understanding Drivers of Coronavirus Disease 2019 Vaccine Hesitancy Among Blacks”. Clinical Infectious Disease (2021): 1784‑178
  18. National Institute of Statistics of Niger (2024).
  19. World Bank Open Data | Data (2024).
  20. Iliyasu Z., et al. “They have produced a vaccine, but we doubt if COVID-19 exists »: correlates of COVID-19 vaccine acceptability among adults in Kano, Nigeria”. Human Vaccines Immunotherapy11 (2021): 4057‑4064.
  21. “COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates” (2024).
  22. “Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study”. BMC Public Health (2024).
  23. Ebrahimi OV., et al. “Risk, Trust, and Flawed Assumptions: Vaccine Hesitancy During the COVID-19 Pandemic”. Frontiers in Public Health 9 (2021): 700213.
  24. Kreps S., et al. “Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination”. JAMA Network Open10 (2020): e2025594‑e2025594.
  25. Prati G. “Intention to receive a vaccine against SARS-CoV-2 in Italy and its association with trust, worry and beliefs about the origin of the virus”. Health Education Research6 (2020): 505‑511.
  26. Taylor S., et al. “A Proactive Approach for Managing COVID-19: The Importance of Understanding the Motivational Roots of Vaccination Hesitancy for SARS-CoV2”. Frontiers in Psychology 11 (2020): 575950.
  27. Kwok KO., et al. “Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey”. The International Journal of Nursing Studies 114 (2021): 103854.
  28. Kessels R., et al. “Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general”. Vaccine33 (2021): 4716‑4722.
  29. AlShurman BA., et al. “What Demographic, Social, and Contextual Factors Influence the Intention to Use COVID-19 Vaccines: A Scoping Review”. International Journal of Environmental Research and Public Health 17 (2021): 9342.
  30. Wang K., et al. “Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey”. Vaccine45 (2020): 7049‑7056.
  31. Roozenbeek J., et al. “Susceptibility to misinformation about COVID-19 around the world”. Royal Society Open Science 10 (2020): 201199.
  32. Fisher KA., et al. “Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults”. Annals of Internal Medicine 12 (2020): 964‑973.

Citation

Citation: Boulama Mamadou Boulama Malam., et al. “Determinants of COVID-19 Vaccine Hesitancy of the Population of the Gaweye Health District (DS) in Niger”.Acta Scientific Medical Sciences 8.8 (2024): 151-157.

Copyright

Copyright: © 2024 Boulama Mamadou Boulama Malam., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US